Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by RelevantStockon Oct 20, 2020 3:25pm
284 Views
Post# 31749357

RE:OK so why now?

RE:OK so why now?I see two possible explanations, and both imply that things are going maybe better than expected, and our institutionnal investors are pushing things forward as much as they can.

The first explanation is covid revenue is steady and the demand is so huge that they still need to ramp up even more, as they see this thing is going to be the headline for still more than a year.  You cannot spit on millions of revenue per month no matter what your company's mission is.

The second explanation has been put by other members here, is that they want to fill one of the (nasdaq?) requirements of a minimum cash in hand for uplisting (10 millions?).  I don't have the info at hand, but it's possible too.

We passed through a reverse split and another offering and we are still at the same sp as before.  It's amazing I have never seen that.  But I have not seen too many times a company doing those events when they are at their best in terms of performance neither.

I am patient.  I am confident it'll pay off big time.  For me it's just a matter of wether making a lot of money with szls or making a crazy shiet boat load of money with it.  I feel we are very lucky to have Echelon and Clarus with us, they are an incredible force in this company and it's well felt.
Bullboard Posts